Tender

Provision of Haemodialysis and Plasma Pheresis In Centre Equipment and Associated Consumables

  • NHS Wales Shared Services Partnership

F02: Contract notice

Notice identifier: 2021/S 000-000328

Procurement identifier (OCID): ocds-h6vhtk-02888e

Published 8 January 2021, 9:24am



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership

Cardiff and Vale University Local Health Board, Procurement Services, Woodlands House, Maes-Y-Coed Road

Cardiff

CF14 4HH

Contact

Emma Lane

Email

emma.lane@wales.nhs.uk

Telephone

+44 02921836450

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

http://nwssp.nhs.wales/ourservices/procurement-services/

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

www.etenderwales.bravosolution.co.uk

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

www.etenderwales.bravosolution.co.uk

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of Haemodialysis and Plasma Pheresis In Centre Equipment and Associated Consumables

Reference number

CAV-OJEU-PROJECT46164

two.1.2) Main CPV code

  • 33181520 - Renal dialysis consumables

two.1.3) Type of contract

Supplies

two.1.4) Short description

The NHS Wales Shared Services Partnership, hosted by Velindre NHS Trust are acting on behalf of Cardiff and Vale University Local Health Board who are seeking to to establish a contract for the provision of Haemodialysis and Plasma Pheresis In Centre Equipment and Associated Consumables.

The Nephrology and Transplant Directorate at the University Hospital of Wales (UHW) serves a population of approximately 1.4 million people in South East Wales, providing a complete range of diagnostic and therapeutic services including dialysis and transplantation to adult patients. Our take-on rate for Renal Replacement Therapy (RRT) has recently been approximately 120 patients per million per annum, and approximately 700 patients receive a dialysis therapy at any one time. Our program emphasises the benefits of home therapies, and currently there are approximately 35 patients receiving home haemodialysis with a further 60 on peritoneal therapies.

Outpatient Haemodialysis is delivered through a network of Satellite units across the region, supported by The David Thomas Haemodialysis Unit (DTU) on-site at UHW. DTU has recently been extensively refurbished and has seven stations, providing capacity for up to 28 patients per week. The unit focuses on providing outpatient dialysis for patients with complex needs who require specific care best provided on a Hospital site, and also treats Chronic Haemodialysis patients who may be admitted to UHW with non-renal problems.

Inpatient dialysis is provided to the Directorate’s patients on a 27 bedded Nephrology ward (Ward B5), and on the 20-bedded Cardiff Transplant Unit (CTU) at UHW. Therapies are provided to Chronic Haemodialysis patients, patients with Acute Kidney Injury, and patients in the pre-and post-transplant settings. Plasma exchange is provided where clinically indicated in the management of acute vasculitides, and plasmapheresis may be provided as part of the ABO Incompatible Transplant program as well as in the management of Acute Graft Rejection.

two.1.5) Estimated total value

Value excluding VAT: £3,000,000

two.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

two.2) Description

two.2.1) Title

Haemodialysis In Centre Equipment and Associated Consumables

Lot No

1

two.2.2) Additional CPV code(s)

  • 33181520 - Renal dialysis consumables

two.2.3) Place of performance

NUTS codes
  • UKL22 - Cardiff and Vale of Glamorgan

two.2.4) Description of the procurement

Under this lot, the Health Board is seeking to establish the provision of Haemodialysis In Centre Equipment and Associated Consumables.

This requirement is for the David Thomas Dialysis unit; Ward B5 and Cardiff Transplant Unit University Hospital. The provider must be capable of delivering clinically acceptable standards for the delivery of a wide and extensive range of haemodialysis as well as the support structure to upgrade and replace such equipment within an agreed schedule of delivery.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

Yes

Description of renewals

The contract will have an option to extend for up two years at the sole discretion of the Health Board which is included in the months duration within this notice.

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Plasma Pheresis In Centre Equipment and associated consumables and maintenance support

Lot No

2

two.2.2) Additional CPV code(s)

  • 33181500 - Renal consumables

two.2.3) Place of performance

NUTS codes
  • UKL22 - Cardiff and Vale of Glamorgan

two.2.4) Description of the procurement

Under this lot, the Health Board is seeking to establish a contract for the provision of Plasma Pheresis In Centre Equipment and associated consumables and maintenance support.

This requirement is for a service to treat approximately 2 patients per year with peri transplant anti body removal to enable either ABOi or HLA incompatible transplantation or approx. 12 patient for treatment of anti body mediated rejection.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

Yes

Description of renewals

The contract will have an option to extend for up two years at the sole discretion of the Health Board which is included in the months duration within this notice.

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

8 February 2021

Local time

2:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 190 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

8 February 2021

Local time

2:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

six.3) Additional information

Please note additional information on this procurement:

1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.

2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the tender and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.

3. The Contracting Authority will not accept completed tenders after the stated closing date.

4. All documents to be priced (where applicable) in sterling and all payments made in sterling.

5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.

6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board.

7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_85384 for all tender documentation.

NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=107181

(WA Ref:107181)

The buyer considers that this contract is suitable for consortia.

six.4) Procedures for review

six.4.1) Review body

High Court

London

Country

United Kingdom

six.4.3) Review procedure

Precise information on deadline(s) for review procedures

NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.

Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.